Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferroquine induced blood-stage malaria study in healthy volunteers
ACTRN12613001040752Phase 2Completed
- Sponsor
- QIMR Berghofer Medical Research Institute
- Start
- Oct 2013
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ferroquine in malaria and Falciparum malaria (PF) (2 cohorts), sponsored by QIMR Berghofer Medical Research Institute. Primary endpoint: Pharmacokinetic-pharmacodynamic relationship of ferroquine on parasite clearance. Started Oct 2013; status: completed.
02
Drugs
ferroquine
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on ACTRN12613001040752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001040752.